ETRA · Forms 3, 4, 5
Insider trades at Electra Therapeutics, Inc.
2 insiders bought $40M of Electra Therapeutics, Inc. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for Electra Therapeutics, Inc. (ETRA) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Carl L Gordon | Director | Conversion | 2,002,310 | Form 4 | |||
| Carl L Gordon | Director | Conversion | 1,087,934 | Form 4 | |||
| Carl L Gordon | Director | Conversion | 1,703,314 | Form 4 | |||
| Carl L Gordon | Director | Buy | 333,333 | $15.00 | $5M | Form 4 | |
| Carl L Gordon | Director | Conversion | 758,279 | Form 4 | |||
| Carl L Gordon | Director | Buy | 1,000,000 | $15.00 | $15M | Form 4 | |
| ORBIMED ADVISORS LLC | Director | Conversion | 2,002,310 | Form 4 | |||
| ORBIMED ADVISORS LLC | Director | Conversion | 1,087,934 | Form 4 | |||
| ORBIMED ADVISORS LLC | Director | Conversion | 1,703,314 | Form 4 | |||
| ORBIMED ADVISORS LLC | Director | Buy | 333,333 | $15.00 | $5M | Form 4 | |
| ORBIMED ADVISORS LLC | Director | Conversion | 758,279 | Form 4 | |||
| ORBIMED ADVISORS LLC | Director | Buy | 1,000,000 | $15.00 | $15M | Form 4 | |
| Westlake BioPartners Fund I, L.P. | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| Gary S. Koe | Chief Technical Officer | Conversion | 63,656 | Form 4 | |||
| Nancy Stagliano | Director | Conversion | 255,635 | Form 4 | |||
| Graham Parry | Chief Scientific Officer | Conversion | 85,504 | Form 4 | |||
| Dong Quehuong (Kathy) | President & CEO | Conversion | 455,484 | Form 4 | |||
| ORBIMED ADVISORS LLC | Director | Became an insider (Form 3) | Form 3 | ||||
| David J. Tucker | Principal Accounting Officer | Became an insider (Form 3) | Form 3 | ||||
| Matthew K Fust | Director | Became an insider (Form 3) | Form 3 | ||||
| Kim-Hien Dao | Chief Medical Officer | Became an insider (Form 3) | Form 3 | ||||
| Graham Parry | Chief Scientific Officer | Became an insider (Form 3) | Form 3 | ||||
| Graham Parry | Principal Accounting Officer | Became an insider (Form 3) | Form 3 | ||||
| Gary S. Koe | Chief Technical Officer | Became an insider (Form 3) | Form 3 | ||||
| Carl L Gordon | Director | Became an insider (Form 3) | Form 3 | ||||
| Christopher William Clark | Chief Financial Officer | Became an insider (Form 3) | Form 3 | ||||
| Nancy Stagliano | Director | Became an insider (Form 3) | Form 3 | ||||
| Dong Quehuong (Kathy) | President & CEO | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.